Literature DB >> 8651304

Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

R Albarosa1, B M Colombo, L Roz, I Magnani, B Pollo, N Cirenei, C Giani, A M Conti, S DiDonato, G Finocchiaro.   

Abstract

The loss of genetic material on chromosome 10q is frequent in different tumors and particularly in malignant gliomas. We analyzed 90 of these tumors and found loss of heterozygosity (LOH) in >90% of the informative loci in glioblastoma multiforme (GBM). Initial studies restricted the common LOH region to 10q24-qter. Subsequently, the study of a pediatric GBM suggested D10S221 and D10S209, respectively, as centromeric and telomeric markers of a 4-cM LOH region. It is interesting to note that, in one subset of cells from this tumor, locus D10S209 seems involved in the allelic imbalance of a larger region, with D10S214 as telomeric marker. This 17-cM region contains the D10S587-D10S216 interval of common deletion recently defined on another set of gliomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651304      PMCID: PMC1915052     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Linkage mapping of human chromosome 10 microsatellite polymorphisms.

Authors:  R A Decker; J Moore; B Ponder; J L Weber
Journal:  Genomics       Date:  1992-03       Impact factor: 5.736

2.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

Review 3.  Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

Authors:  A E Pegg
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Localization of the human O6-methylguanine-DNA methyltransferase gene to chromosome 10q24.33-qter.

Authors:  E Gardner; B Rydberg; P Karran; B A Ponder
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

5.  Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.

Authors:  S A Rempel; K Schwechheimer; R L Davis; W K Cavenee; M L Rosenblum
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

6.  A functional marker centromere with no detectable alpha-satellite, satellite III, or CENP-B protein: activation of a latent centromere?

Authors:  L E Voullaire; H R Slater; V Petrovic; K H Choo
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

7.  Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma.

Authors:  S L Speaks; W G Sanger; A S Masih; D S Harrington; M Hess; J O Armitage
Journal:  Genes Chromosomes Cancer       Date:  1992-10       Impact factor: 5.006

8.  Loss of heterozygosity for 10q loci in human gliomas.

Authors:  B K Rasheed; G N Fuller; A H Friedman; D D Bigner; S H Bigner
Journal:  Genes Chromosomes Cancer       Date:  1992-07       Impact factor: 5.006

9.  Loss of the chromosomal region 10q23-25 in prostate cancer.

Authors:  I C Gray; S M Phillips; S J Lee; J P Neoptolemos; J Weissenbach; N K Spurr
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

10.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  22 in total

1.  PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.

Authors:  H Sasaki; M C Zlatescu; R A Betensky; Y Ino; J G Cairncross; D N Louis
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review).

Authors:  Xiang Zhang; Wei Zhang; Wei-Dong Cao; Gang Cheng; Yong-Qiang Zhang
Journal:  Exp Ther Med       Date:  2011-10-18       Impact factor: 2.447

3.  Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.

Authors:  Anna Luisa Di Stefano; Victor Enciso-Mora; Yannick Marie; Virginie Desestret; Marianne Labussière; Blandine Boisselier; Karima Mokhtari; Ahmed Idbaih; Khe Hoang-Xuan; Jean-Yves Delattre; Richard S Houlston; Marc Sanson
Journal:  Neuro Oncol       Date:  2012-11-16       Impact factor: 12.300

4.  Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.

Authors:  H Fujisawa; M Kurrer; R M Reis; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  PAX6 suppresses growth of human glioblastoma cells.

Authors:  Yi-Hong Zhou; Xiaosong Wu; Fang Tan; Yue-Xi Shi; Tricia Glass; T J Liu; Kyle Wathen; Kenneth R Hess; Joy Gumin; Frederick Lang; W K Alfred Yung
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 6.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 7.  Prognostic factors for anaplastic astrocytomas.

Authors:  Alessia Compostella; Alicia Tosoni; Valeria Blatt; Enrico Franceschi; Alba A Brandes
Journal:  J Neurooncol       Date:  2006-09-26       Impact factor: 4.130

8.  Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.

Authors:  Kinya Terada; Takashi Tamiya; Shigeru Daido; Hirokazu Kambara; Hiroaki Tanaka; Yasuhiro Ono; Kengo Matsumoto; Sachio Ito; Mamoru Ouchida; Takashi Ohmoto; Kenji Shimizu
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

9.  Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer.

Authors:  Ladan Vakil; Reza Najafipour; Nasser Rakhshani; Farhad Zamani; Arman Morakabati; Amir Javadi
Journal:  Tumour Biol       Date:  2016-01-09

10.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.